Effects of nisoxetine, a selective noradrenaline transporter blocker, on sleep in rats

Pharmacology Biochemistry and Behavior

Volumn 58, Issue 2, 1997, Pages 369-372

  Python, Agathe ^a   Charnay, Yves ^a   Mikolajewski, Richard ^a   Merica, Helli ^a   Hilaire, Zara De Saint ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Nisoxetine; Rat; Sleep

Indexed keywords

NISOXETINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; MALE; NONHUMAN; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; RAT; REM SLEEP; SLEEP PATTERN; SLEEP TIME;

ANIMALS; CARRIER PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUOXETINE; MALE; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; RATS; RATS, WISTAR; SLEEP; SYMPORTERS;

ANIMALIA;

EID: 0030867295     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(97)00255-4     Document Type: Article

References (29)

1. Cespuglio R., Gomez M. E., Faradji H., Jouvet M. Alterations in the sleep-wake cycle induced by cooling of the locus coeruleus area. Electroencephalogr. Clin. Neurophysiol. 54:1982;570-578.
2. 3H]Nisoxetine binding sites in the cat brain. An autoradiographic study Neuroscience. 69:1995;259-270.
3. 3H]noradrenaline uptake and effect of DSP-4 lesioning and antidepressant treatments Neuropharmacology. 35:1996;63-70.
4. Danguir J., De Saint Hilaire-Kafi S. Reversal of desipramine-induced suppression of paradoxical sleep by a long-acting somatostatin analogue (octreotide) in rats. Neurosci. Lett. 98:1989;154-158.
5. Datta S., Mohan Kumar V., Chhina G. S., Singh B. Tonic activity of medial preoptic norepinephrine mechanism for body temperature maintenance in sleeping and awake rats. Brain Res. Bull. 15:1985;447-451.
6. De-Boer T., Ruigt G. S. F. The selective alpha-2-adrenoceptor antagonist mirtazapine (Org 3770) enhances noradrenergic and 5-HT(1A)-mediated serotonergic neurotransmission. CNS Drugs. 4(suppl. 1):1995;29-38.
7. Gillin J. C., Sitaram N., Wehr T., Duncun W. C., Pat R., Murphy D. L., Mendelson W. B., Wyatt R. J., Bunney W. E. Sleep and affective illness. Post R. M., Ballenger J. C. Neurobiology of mood disorders. 1984;157 Williams and Wilkins Company, Baltimore/London.
8. Hilakivi I. The role of β- and α-adrenoceptors in the regulation of the stages of the sleep-waking cycle in the cat. Brain Res. 277:1983;109-118.
9. Hobson J. A., McCarley R. W., Wyzinski P. W. Sleep cycle oscillation. Reciprocal discharge by two brainstem neuronal groups Science. 189:1975;55-58.
10. Jones B. E. Paradoxical sleep and its chemical/structural substrates in the brain. Neuroscience. 40:1991;637-656.
11. Jouvet M. Basic mechanisms. Paradoxical sleep mechanisms. Sleep. 17:1994;S77-S83.
12. Justafre J. C., Gaillard J. M. Diminution du sommeil paradoxal chez le rat sous antidépresseur tricyclique. Rôle de l'inhibition collatérale Rev. Electroencephalogr. Neurophysiol. 11:1981;228-235.
13. Katoh A., Eigyo M., Ishibashi C., Naitoh Y., Takeuchi M., Ibii N., Ikeda M., Matsushita A. Behavioral and electroencephalographic properties of duloxetine (LY248686), a reuptake inhibitor of norepinephrine and serotonin, in mice and rats. J. Pharmacol. Exp. Ther. 272:1995;1067-1075.
14. Kupfer D. J., Spiker D. G., Rossi A., Coble P. A., Shaw D., Ulrich R. Nortriptyline and EEG in depressed patients. Biol. Psychiatry. 17:1982;535-546.
15. McCarley R. W. REM sleep and depression. Common neurobiological mechanisms Am. J. Psychiatry. 139:1982;565-570.
16. McGintry D. J., Harper R. M., Fairbanks M. K. Neuronal unit activity and the control of sleep states. Weitzman E. D. Advances in sleep research. 1974;173-216 Spectrum Publications, New York.
17. Mignot E., Renaud A., Nishino S., Arrigoni J., Guilleminault C., Dement W. C. Canine cataplexy is preferentially controlled by adrenergic mechanisms. Evidence using monoamine selective uptake inhibitors and release enhancers Psychopharmacology. 113:1993;76-82.
18. Monti J. M., D'Angelo L., Jantos H., Barbeito L., Abo V. Effect of DSP-4, a noradrenergic neurotoxin, on sleep and wakefulness and sensitivity to drugs acting on adrenergic receptors in the rat. Sleep. 11:1988;370-377.
19. Reynolds C. F., Kupfer D. J. Sleep research in affective illness. State of art circa 1987 Sleep. 10:1987;199-211.
20. Ross R. J., Gresch P. J., Ball W. A., Sanford L. D., Morrison A. R. REM sleep inhibition by desipramine. Evidence for an alpha-1 adrenergic mechanism Brain Res. 701:1995;129-134.
21. Sakai K. Anatomical and physiological basis of paradoxical sleep. McGinty D. J.et al. Brain mechanisms of sleep. 1985;111-137 Raven Press, New York.
22. Sakai K. Physiological properties and afferent connections of the locus coeruleus and adjacent tegmental neurons involved in the generation of paradoxical sleep in the cat. Prog. Brain Res. 88:1991;31-45.
23. Slater I. H., Jones G. T., Moore R. A. Depression of REM sleep in cats by nisoxetine, a potential antidepressant drug. Psychopharmacol. Commun. 2:1976;181-188.
24. 3H]Nisoxetine. A radioligand for quantification of norepinephrine uptake sites by autoradiography or by homogenate binding J. Pharmacol. Exp. Ther. 260:1992;427-436.
25. Vertes R. P. Brainstem control of the events of REM sleep. Prog. Neurobiol. 22:1984;241-288.
26. Wilson S. J., Glue P., Nutt D. J. The effects of the alpha-2-adrenoceptor antagonist idazoxan on sleep in normal volunteers. J. Psychopharmacol. 5:1991;105-110.
27. Wong D. T., Bymaster F. P. The comparison of fluoxetine and nisoxetine with tricyclic antidepressants in blocking the neurotoxicity of p-chloroamphetamine and 6-hydroxydopamine in the rat brain. Res. Commun. Chem. Pathol. Pharmacol. 15:1976;221-231.
28. Wong D. T., Bymaster F. P. Effect of nisoxetine on uptake of catecholamines in synaptosomes isolated from discrete regions of rat brain. Biochem. Pharmacol. 25:1976;1979-1983.
29. Wong D. T., Horng J. S., Bymaster F. P. d1-N-methyl-3-(o-methoxyphenoxy)-3-phenylpropylamine hydrochloride, LILLY 94939, a potent inhibitor for uptake of norepinephrine into rat brain synaptosomes and heart. Life Sci. 17:1975;755-760.